Evidence map›Paper›PMID 9479574›Full record

ReviewImmunologic research1998

B cells and autoantibodies in the pathogenesis of lupus nephritis.

M P Madaio

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

M P MadaioPenn Center for Molecular Studies of Kidney Diseases, Department of Medicine, University of Pennsylvania, Philadelphia 19104-6144, USA.
University of Pennsylvania · US

Funding

POSITIONAL CLONING OF KD/KD GENE PRODUCING SOPONTANEOUS INTERSTITIAL NEPHRITISP50DK045191 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MADAIO, MICHAEL P · 1992 to 2002
$1.8M
IMMUNOLOGIC MECHANISMS OF LUPUS NEPHRITISR01DK033694 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MADAIO, MICHAEL P · 1986 to 2001
$499k
AUTOREACTIVE T-CELLS IN MURINE LUPUS NEPHRITISR01AI027915 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI MADAIO, MICHAEL P · 1989 to 1996
–
NIAID NIH HHS AI 27915NIDDK NIH HHS DK 33694NIDDK NIH HHS DK45191
6 · The paper itself

Abstract

Although autoantibodies and autoantibody-producing B cells are crucial for the initiation of lupus nephritis, their precise role in the development of the nephritic lesions is incompletely understood. This article summarizes the results of recent work in our laboratory related to this area. They indicate that not all autoantibodies are pathogenic. Furthermore, among the pathogenic subset, individual immunoglobulins produce clearly distinguishable immune deposit patterns in specific glomerular locations and this is associated with different disease profiles (i.e., inflammation, proteinuria). The variation in immune deposit formation induced by the individual autoantibodies are reminiscent of the different lesions in lupus patients, and they appear to be related to differences in the reactivity of autoantibodies with specific glomerular antigens. Thus, it appears that the predominant interaction in a given individual influences the morphologic and clinical expression of disease. Autoantibody-producing B cells also influence the activation of autoreactive T cells that infiltrate the kidney to produce vasculitis and interstitial nephritis, and the potential mechanisms responsible for this phenomenon are discussed.

Indexed as

AnimalsAutoantibodiesB-LymphocytesHumansLupus NephritisLymphocyte CooperationT-LymphocytesAutoantibodies

Identifiers

PMID9479574
OpenAlexW2032730805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.